1.8.98.2	Adenocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24189098&form=6&db=m	Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma.	diagnostic usage,ongoing research,unassigned	3,4,0	
1.8.98.2	Adenocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32411320&form=6&db=m	Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,3,2,4	
1.8.98.2	Brain Injuries	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25407820&form=6&db=m	Sulfiredoxin-1 Attenuates Oxidative Stress via Nrf2/ARE Pathway and 2-Cys Prdxs After Oxygen-Glucose Deprivation in Astrocytes.	causal interaction,therapeutic application,unassigned	1,2,0	
1.8.98.2	Brain Ischemia	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25955519&form=6&db=m	Sulfiredoxin-1 exerts anti-apoptotic and neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen-glucose deprivation and hydrogen peroxide.	causal interaction,therapeutic application,unassigned	3,4,0	
1.8.98.2	Brain Ischemia	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28552673&form=6&db=m	Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats.	causal interaction,therapeutic application,unassigned	4,1,0	
1.8.98.2	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21742584&form=6&db=m	Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia.	diagnostic usage,ongoing research,therapeutic application,unassigned	3,3,1,0	
1.8.98.2	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22964583&form=6&db=m	Genetic polymorphisms and protein expression of NRF2 and sulfiredoxin predict survival outcomes in breast cancer.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,4,4,1	
1.8.98.2	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25833832&form=6&db=m	Correction: Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer.	causal interaction,diagnostic usage,therapeutic application,unassigned	2,3,1,0	
1.8.98.2	Carcinogenesis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21487000&form=6&db=m	Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.	therapeutic application,unassigned	1,0	
1.8.98.2	Carcinogenesis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23393226&form=6&db=m	Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.	causal interaction,ongoing research,unassigned	1,3,0